BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Poised to Ease Restrictions on Injectable Peptides Af